SUMMARY One hundred and ninety children with atopic eczema were studied prospectively for two and a half years. The mean period of observation was 13 months. Seventy six children (40%) had between them 164 episodes of exacerbation of eczema due to bacterial infection, and in 52 (32%) infection recurred within three months of a previous infection. Twenty five episodes (15%) led to admission to hospital. Staphylococcus aureus was recovered in 97% of episodes, in combination with PI haemolytic streptococci in 62%. Physical signs suggesting infection were pustules, crusting, and a weeping discharge, but these signs alone are not diagnostic, and an exacerbation was only attributed to infection if there was a response to anti-infective treatment. Exacerbation of atopic eczema due to bacterial infection is common, the physical signs of infection are not always clear, and there is a case for a trial of oral antibiotics in any child with troublesome atopic eczema.
example, Leyden et all recovered S aureus not only from more than 90% of isolates taken from chronic eczematous lesions, but also from approximately 70% of isolates taken from unaffected areas of the skin. By contrast, Noble2 found S aureus on the skin in fewer than 5% of isolates taken from various sites in 382 normal children. The high frequency of S aureus carriage in clinically normal skin in patients with atopic eczema may be contamination due to continual dispersion from skin lesions or colonisation. Impaired neutrophil chemotaxis,3 and greater adherence of S aureus to keratinised epithelial cells of atopics4 may contribute to the high rate of skin colonisation.
It is often held that while the skin in atopic eczema is usually colonised with S aureus, bacterial skin infections are uncommon, and less frequent than might be expected in a disease characterised by scratching and excoriation. The presence of pustules, a purulent discharge, crusting combined with weeping ( Figure (a) ), crusting alone (Figure (b) clearly diagnostic. The presence of weeping is unreliable; although it may be due to infection, it may also be the result of a deterioration due to allergy or simply to incessant scratching. The presence of bacteria on eczematous skin is almost universal,9 1( and colonisation cannot be considered a criterion of infection. In this study, the definition of infection included response to anti-infective treatment, usually oral antibiotics. Oral antibiotics were chosen because of the widespread nature of many of the infections, and the severity of some. Topical antibiotics were not used because of the possibility of sensitisation and the difficulty of application to widespread lesions. All patients with physical signs suggesting infection were treated, so the possibility that some lesions might have recovered spontaneously cannot be excluded.
There were 164 episodes of symptomatic bacterial infection affecting 40% of 190 children with atopic eczema during a two and a half year period. This does not include those treated by the general practitioner or those with uncertain response to treatment. The high hospital admission rate partly reflects the severity of some of these cases. It is also partly attributable to the local policy of using short admissions to initiate treatment and teach parents how to continue the same management at home. As in any hospital based study, the patients were selected and contained an excess of severe or intractable cases, but in this group infection was common and caused substantial morbidity.
The importance of S aureus as a skin pathogen is well known, but the frequency of concomitant infection with Pi haemolytic streptococci, 62% in this series, is less well appreciated. This high incidence of streptococci underlines the need for treatment of both streptococci and staphylococci in infected eczema. Flucloxacillin has antistreptococcal activity, and ought to be adequate as a single agent to deal with both bacteria. Previous local experience of treatment failure with flucloxacillin alone, however, led to the addition of phenoxymethylpenicillin. Erythromycin was avoided except in cases of penicillin allergy, because of the high incidence (18%) of erythromycin resistant staphylococci. Cefadroxil was sometimes used, as a single agent to cover both pathogens and having the advantage of requiring only twice daily dosage. The role of topical antiseptics, topical antiseptic-corticosteroid preparations, antiseptics in the bath, and intranasal neomycin and chlorhexidine cream are not clarified by this study.
Thirty two per cent of the P haemolytic streptococci were not Lancefield group A. The data do not distinguish between the relative pathogenicity of different strains of streptococci in atopic eczema, nor do they prove the individual importance of either streptococci or staphylococci. Treatment was directed against both organisms. Obtaining bacteriology swabs from the skin was atraumatic, but taking nose and throat swabs was disliked. The results indicate that taking nose and throat swabs is unnecessary, for it did not detect organisms that could not be more simply recovered from the skin, and did not influence treatment.
This study shows that it is common for bacterial infection to cause exacerbations of atopic eczema. The signs of infection are not always clear, and there is a case7 for a trial of oral antibiotic treatment in any child with troublesome atopic eczema.
